Tweet
Yet Another CPAP Killer
Tennis-balls-in-PJs reworked:
Sure, it will relieve positional snoring and maybe sleep apnoea to an extent, but wouldn't it create big sores to lie on one side all night? And turning over would mean having to wake up, which interrupts sleep in itself.
Will be interesting to see what the FDA thinks and whether any papers will appear.
Krachman is leading research on an experimental device to help patients who suffer from positional sleep apnea. Positional sleep apnea refers to patients who have episodes where they stop breathing when they're on their back, but when they are on their side, the abnormal breathing resolves. Fifty percent of patients with mild sleep apnea (those who experience anywhere from five to 15 events an hour) and 20 percent of people with moderate sleep apnea (15 to 30 events an hour) have positional sleep apnea. Krachman explains how wearing the device, called Zzoma, works to reduce those episodes.
Untreated sleep apnea can lead to a host of other medical problems. Just having sleep apnea is an independent risk factor for developing high blood pressure, coronary disease and heart failure. That's why Krachman hopes the FDA approves Zzoma to treat positional sleep apnea, to give sufferers an effective alternative to the burden of CPAP.
Sure, it will relieve positional snoring and maybe sleep apnoea to an extent, but wouldn't it create big sores to lie on one side all night? And turning over would mean having to wake up, which interrupts sleep in itself.
Will be interesting to see what the FDA thinks and whether any papers will appear.
Comment